Cargando…
Hyperferritinemia, Low Circulating Iron and Elevated Hepcidin May Negatively Impact Outcome in COVID-19 Patients: A Pilot Study
Inflammation in COVID-19 produces intracellular iron overload with low circulating iron available for metabolic processes. The accumulated intracellular iron generates reactive species of oxygen and results in ferroptosis, a non-programmed cell death. Since no organ is spared, iron dysmetabolism inc...
Autores principales: | Szabo, Robert, Petrisor, Cristina, Bodolea, Constantin, Simon, Robert, Maries, Ioana, Tranca, Sebastian, Mocan, Teodora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311882/ https://www.ncbi.nlm.nih.gov/pubmed/35883855 http://dx.doi.org/10.3390/antiox11071364 |
Ejemplares similares
-
Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
por: Szabo, Robert, et al.
Publicado: (2023) -
Iron, Copper, and Zinc Homeostasis: Physiology, Physiopathology, and Nanomediated Applications
por: Szabo, Robert, et al.
Publicado: (2021) -
Clinical versus Ultrasound Measurements of Hyomental Distance Ratio for the Prediction of Difficult Airway in Patients with and without Morbid Obesity
por: Petrișor, Cristina, et al.
Publicado: (2020) -
Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk
por: An, Peng, et al.
Publicado: (2015) -
Increased Body Mass Index may lead to Hyperferritinemia Irrespective of Body Iron Stores
por: Alam, Faiza, et al.
Publicado: (2015)